Ventas (NYSE:VTR) Stock Gets Price Target Reduction from Mizuho

Ventas (NYSE:VTR – Free Report) had its price objective lowered by Mizuho from $104.00 to $101.00 in a research report sent to investors on Monday morning,Benzinga reports. The firm currently has an outperform rating on the real estate investment trust’s stock.

A number of other research analysts have also issued reports on VTR. Wells Fargo & Company boosted their target price on Ventas from $96.00 to $102.00 and gave the company an “overweight” rating in a report on Monday. Evercore set a $100.00 price target on Ventas and gave the stock an “outperform” rating in a report on Monday, September 21st. JPMorgan Chase & Co. lifted their price objective on shares of Ventas from $94.00 to $104.00 and gave the company an “overweight” rating in a research report on Wednesday, September 2nd. Barclays lowered their price objective on shares of Ventas from $102.00 to $91.00 and set an “equal weight” rating on the stock in a research report on Tuesday, October 13th. Finally, Royal Bank Of Canada boosted their price objective on shares of Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a research note on Friday, August 14th. Seventeen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $99.82.

Get Our Latest Analysis on Ventas

Ventas Stock Performance

NYSE VTR opened at $88.09 on Monday. The company has a quick ratio of 0.43, a current ratio of 0.43 and a debt-to-equity ratio of 0.78. Ventas has a 52-week low of $73.82 and a 52-week high of $101.60. The business’s 50-day moving average price is $86.31 and its 200 day moving average price is $87.20. The firm has a market cap of $46.59 billion, a P/E ratio of 23.23, a P/E/G ratio of 3.61 and a beta of 0.77.

Ventas (NYSE:VTR – Get Free Report) last posted its quarterly earnings data on Tuesday, October 27th. The real estate investment trust reported $0.13 EPS for the quarter, missing the consensus estimate of $0.98 by ($0.85). Ventas had a net margin of 3.86% and a return on equity of 1.86%. The company had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.77 billion. During the same period in the prior year, the company earned $0.88 earnings per share. The firm’s revenue was up 23.0% on a year-over-year basis. On average, equities research analysts expect that Ventas will post 3.89 earnings per share for the current year.

Ventas Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Wednesday, September 30th were given a $0.52 dividend. The ex-dividend date was Wednesday, September 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. Ventas’s dividend payout ratio (DPR) is presently 392.45%.

Hedge Funds Weigh In On Ventas

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. purchased a new stake in shares of Ventas during the 2nd quarter worth $4,953,439,000. Legal & General Group Plc acquired a new position in shares of Ventas during the 2nd quarter worth $501,850,000. Deutsche Bank AG purchased a new position in shares of Ventas in the 2nd quarter valued at about $451,822,000. Bank of America Corp DE purchased a new position in shares of Ventas in the 2nd quarter valued at about $390,395,000. Finally, Canada Pension Plan Investment Board purchased a new position in shares of Ventas in the 2nd quarter valued at about $387,748,000. Institutional investors and hedge funds own 94.18% of the company’s stock.

About Ventas

(Get Free Report)

Ventas, Inc. is a real estate investment trust focused on properties and services that support the health care and senior living sectors. Its portfolio includes senior housing communities, outpatient medical buildings, and research and life science facilities. The company owns and invests in properties across the United States, Canada, and the United Kingdom. Many of its communities and facilities are operated by health care and senior living providers, while Ventas provides real estate capital and asset management.

Further Reading

Analyst Recommendations for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.